Quarterly ResultAug 6, 2026, 05:03 PM
Health Catalyst Reports $151.6M YTD Net Loss, $122.5M Goodwill Impairment
AI Summary
Health Catalyst, Inc. reported a significant net loss of $151.6 million for the six months ended June 30, 2026, largely driven by a $122.5 million goodwill impairment charge. Total revenue for the second quarter decreased by 12.7% to $70.5 million compared to the prior year. Despite the losses, the company saw an improvement in net cash provided by operating activities, reaching $18.8 million year-to-date. The balance sheet also reflects $91.4 million in assets held for sale.
Key Highlights
- Year-to-date net loss was $151.6 million, or $(2.07) per share.
- Recorded $122.5 million in goodwill impairment for the six months ended June 30, 2026.
- Q2 2026 total revenue decreased 12.7% to $70.5 million.
- Q2 2026 net loss was $40.5 million, or $(0.55) per share.
- Total assets decreased to $358.6 million from $502.6 million as of Dec 31, 2025.
- Net cash provided by operating activities improved to $18.8 million YTD 2026.
- Identified $91.4 million in assets held for sale as of June 30, 2026.
- Stockholders' equity declined to $100.8 million from $245.8 million.
Price Impact
More from HCAT